Surgical orbital decompression for thyroid eye disease

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Boboridis, Kostas G ^a   Bunce, Catey ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DECOMPRESSION SURGERY; DISEASE SEVERITY; ENDOCRINE OPHTHALMOPATHY; EYE SURGERY; GROUPS BY AGE; INTERMETHOD COMPARISON; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SCORING SYSTEM; STRABISMUS; SURGICAL ORBITAL DECOMPRESSION; THERAPY EFFECT; VISUAL IMPAIRMENT;

EID: 70249129722     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007630     Document Type: Review

References (23)

1. Baldeschi L, MacAndie K, Hintschich C,Wakelkamp IM, Prummel MF, Wiersinga WM. The removal of the deep lateral wall in orbital decompression: its contribution to exophthalmos reduction and influence on consecutive diplopia. American Journal of Ophthalmology 2005;140(4):642-647 (Pubitemid 41455304)
2. Bartalena L, Wiersinga WM, Pinchera A. Graves' ophthalmopathy: state of the art and perspectives. Journal of Endocrinological Investigation 2004;27(3):295-301. (Pubitemid 38607484)
3. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008. Available from www.cochrane-handbook. org.
4. Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-136
5. Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
6. Hurwitz JJ, Birt D. An individualized approach to orbital decompression in Graves' orbitopathy. Archives of Ophthalmology 1985;103 (5):660-665 (Pubitemid 15052401)
7. Kendall-Taylor P. The pathogenesis of Graves' ophthalmopathy. Clinics in Endocrinology and Metabolism 1985;14(2):331-349
8. Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Rocchi R, et al.Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study. Journal of Clinical Endocrinology & Metabolism 2001;86(8):3562-3567 (Pubitemid 32755944)
9. McCord CD, Jr. Current trends in orbital decompression. Ophthalmology 1985;92(1):21-33.
10. Mourits MP, Koornneef L, Wiersinga WM, Prummel MF. Berghout A. van der Gaag R. Orbital decompression for Graves' ophthalmopathy by inferomedial, by inferomedial plus lateral, and by coronal approach. Ophthalmology 1990;97(5):636-641 (Pubitemid 20150719)
11. Mourits MP, Prummel MF, Wiersinga WM, Koornneef L. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clinical Endocrinology (Oxf ) 1997;47(1):9-14. (Pubitemid 27313981)
12. Mourits MP, Rose GE, Garrity JA, Nardi M,Matton G, Koornneef L. Surgical management of Graves' ophthalmopathy. In: Prummel MF editor(s). Recent developments in Graves' Ophthalmopathy. Boston, Dordrecht, London,: Kluwer Academic Publishers, 2000:133-152.
13. Paridaens D, Hans K, van Buitenen S, Mourits MP. The incidence of diplopia following coronal and translid orbital decompression in Graves' orbitopathy. Eye 1998;12(Pt 5):800-805 (Pubitemid 28482803)
14. Perros P, Crombie AL, Matthews JN, Kendall-Taylor P. Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic. Clinical Endocrinology 1993;38(4):367-372 (Pubitemid 23105068)
15. Perros P, Kendall-Taylor P. Thyroid-associated ophthalmopathy: pathogenesis and clinicalmanagement. BaillieresClinical Endocrinology & Metabolism 1995;9(1):115-135
16. Prummel MF, Mourits MP, Berghout A, Krenning EP, van der Gaag R, Koornneef L, et al. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy. New England Journal of Medicine 1989;321(20):1353-1359 (Pubitemid 19284191)
17. Prummel MF, Terwee CB, Gerding MN, Baldeschi L, Mourits MP, Blank L, et al.Randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy. Journal of Clinical Endocrinology and Metabolism 2004;89(1): 15-20. (Pubitemid 38183852)
18. Rajendram R, Bunce C, Lee RWJ, Morley S. Orbital radiotherapy for adult thyroid eye disease. CochraneDatabase of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD007114] (Pubitemid 351807404)
19. Terwee CB, Gerding MN, Dekker FW, Prummel MF. Wiersinga WM. Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL. British Journal of Ophthalmology 1998;82(7):773-779
20. Walsh TE, Ogura JH. Transantral orbital decompression for malignant exophthalmos. Laryngoscope 1957;67(6):544-568
21. Werner SC. Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. Journal of Clinical Endocrinology and Metabolism 1977;44(1):203-204
22. Wiersinga WM, Bartalena L. Epidemiology and prevention of Graves' ophthalmopathy. Thyroid 2002;12(10):855-860
23. Wiersinga WM, Prummel MF, Terwee CB. Effects of Graves' ophthalmopathy on quality of life. Journal of Endocrinological Investigation 2004;27(3):259-264 (Pubitemid 38607479)